Contact this trialFirst, we need to learn more about you.
BCR-ABL Tyrosine Kinase Inhibitor
Asciminib + Imatinib for Chronic Myeloid Leukemia
Recruiting2 awardsPhase 3
Montreal, Quebec
This trial aims to see if adding a new drug to an existing one can improve cancer treatment in Leukemia patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.